Name - HH&L Acquisition Co
Current / Former Name: HH&L Acquisition Co (Current)
Address: 2001-2002, 20/F, York House, The Landmark, 15 Queen's Road Central, Hong Kong
Phone Number: +852 3752 2888
Investor Relations Contact: N/A
Website - N/A
Warrant Details
Warrant Symbol: HHLA.WS
Warrants Listed: 20,700,000
Ratio: 1-for-1
Cusip Number: E4912L 11 5 / G4461G 11 4
ISIN Number: KYG4461G1144
Parent Stock Symbol: HHLA (Delisted)
Underlying Stock CUSIP: E4912L 10 7
Expiry Date - June 2024 (Liquidated)
Exercise Price: $11.50 USD
Synopsis & Listing Information
HH&L Acquisition Co. was a blank-check company focused on the healthcare and healthcare-related sectors, with a geographical emphasis on the Asian market.
Listing History: The company completed its IPO on February 9, 2021. The public warrants separated and began independent trading on the New York Stock Exchange under the symbol HHLA.WS.
Business Combination: The company entered into definitive merger agreements with various entities over its life cycle, but none successfully closed due to geopolitical cross-border regulation shifts.
Ticker Change: The warrants traded under ticker HHLA.WS until the shell structure was terminated.
Reverse Split Adjustment: No reverse splits were applied to this series due to the lack of an operational business merger.
Current Status: Defunct. The company reached its final extended termination date in mid-2024 without closing a business combination. The board executed a full trust account liquidation to return capital to common shareholders. The public warrants expired completely worthless.
Current / Former Name: HH&L Acquisition Co (Current)
Address: 2001-2002, 20/F, York House, The Landmark, 15 Queen's Road Central, Hong Kong
Phone Number: +852 3752 2888
Investor Relations Contact: N/A
Website - N/A
Warrant Details
Warrant Symbol: HHLA.WS
Warrants Listed: 20,700,000
Ratio: 1-for-1
Cusip Number: E4912L 11 5 / G4461G 11 4
ISIN Number: KYG4461G1144
Parent Stock Symbol: HHLA (Delisted)
Underlying Stock CUSIP: E4912L 10 7
Expiry Date - June 2024 (Liquidated)
Exercise Price: $11.50 USD
Synopsis & Listing Information
HH&L Acquisition Co. was a blank-check company focused on the healthcare and healthcare-related sectors, with a geographical emphasis on the Asian market.
Listing History: The company completed its IPO on February 9, 2021. The public warrants separated and began independent trading on the New York Stock Exchange under the symbol HHLA.WS.
Business Combination: The company entered into definitive merger agreements with various entities over its life cycle, but none successfully closed due to geopolitical cross-border regulation shifts.
Ticker Change: The warrants traded under ticker HHLA.WS until the shell structure was terminated.
Reverse Split Adjustment: No reverse splits were applied to this series due to the lack of an operational business merger.
Current Status: Defunct. The company reached its final extended termination date in mid-2024 without closing a business combination. The board executed a full trust account liquidation to return capital to common shareholders. The public warrants expired completely worthless.
American Financial News
Loading the latest American market news...
American Financial News
Loading the latest American market news...